Investing primarily in entities developing biotechnology solutions for life sciences applications.

	Fax	(02) 9238 0790
	Principal Sector	Health & Pharm
	Principal Industry	Biotechnology
	Listed	2000/08/29
	Homepage	www.biotechcapital.com.au/

Stock Exchange Stock Code   ASX:BTC BTC ZOBEX BTC

Stem Cell Sciences Grants Lexicon Genetics Exclusive IRES Licence (NOV 4, 2005)

Biotech Capital Limited ASX: BTC - Investment In Generic Pharmaceutical Company - Harry Karelis, ASX: BTC Managing Director And Mr Gavin Upiter, Managing Director Of Generic Health Pty Ltd (NOV 23, 2007)

Biotech Capital Limited ASX: BTC - Annual General Meeting - Ms Kathryn Greiner, Chairman And Mr Harry Karelis, MD (NOV 20, 2007)

Biotech Capital Limited ASX: BTC - $2 Million Investment in Sensear - Harry Karelis, Managing Director (JUNE 19, 2007)

Biotech Capital Limited ASX: BTC - Investment in Neurodiscovery Limited - Harry Karelis, Executive Director (MAY 31, 2007)

Biotech Capital Limited ASX: BTC - Market Update - Dr Harry Karelis, Executive Director (APR 4, 2007)

Biotech Capital Limited ASX: BTC - Investor Showcase - Ms Kathryn Greiner, Chairman of Biotech Capital, Dr Jackie Fairley, CEO of Starpharma, Dr Julie-Sheffield Parker, Chief Technical Officer & Mr Harry Karelis, MD of Biotech Capital (FEB 13, 2007)

Biotech Capital Limited ASX: BTC - Annual General Meeting - Ms Kathryn Greiner, Chairman and Mr Harry Karelis, Managing Director (NOV 23, 2006)

Biotech Capital Limited ASX: BTC - Full Year Results for 2006 - Dr Harry Karelis, Executive Director (SEP 14, 2006)

BIOTECH CAPITAL LIMITED ASX: BTC - Content - Mr Harry Karelis, Executive Director (MAY 9, 2006)

BIOTECH CAPITAL LIMITED ASX: BTC - Continence Control - Mr Tony Stephens, CEO (MAY 9, 2006)

BIOTECH CAPITAL LIMITED ASX: BTC - Stemcell Sciences - Dr Peter Mountford, President & CEO (MAY 9, 2006)

BIOTECH CAPITAL LIMITED ASX: BTC - Portfolio Showcase (MAY 9, 2006)